VeriSilicon Microelectronics Shanghai Co Ltd (688521)
Shanghai Stock Exchange · China · prices in CNY · close of 22 Oct 2026
Key indicators
| Last close | CNY 123.50 |
|---|---|
| 52-week range | 118.75 – 375.67 |
| Return, 1 month / 3 months | −40.6% / −48.4% |
| Return, 1 year / 3 years | −28.2% / +120.3% |
| Trend | Below its 200-day average |
| RSI (14) | 26 |
| Volatility (1 year) | 84.6% |
| Worst drawdown (1 year) | -66.7% |
| Average daily value traded | 3,552.11M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
VeriSilicon Microelectronics Shanghai is a semiconductor company based in Shanghai, China. It supplies chip design services and licenses semiconductor intellectual property, including graphics processing, neural network processing and video codec technology, to chipmakers and system companies. Its customers use these designs and licensed blocks to build their own integrated circuits for consumer electronics, automotive and data processing applications. The company works with clients across China and other markets on custom silicon projects.
The shares are listed on the Shanghai Stock Exchange in China under the code 688521, and the price on this page is in Chinese yuan (CNY). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
VeriSilicon Microelectronics Shanghai Co Ltd (688521) trades on the Shanghai Stock Exchange in China. It last closed at CNY 123.50 on 22 October 2026.
Its price-based Market X-Ray is 27 out of 100 (a weak price profile), ranking 2,076 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 28.2% and over the last three months it fell 48.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 7 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -43.9% | ||
| From 52-week high | -66.7% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -48.4% | ||
| 6-month return | -50.8% | ||
| 12-month return, skipping the last month | 21.0% | ||
| Stability (higher is calmer) | 2 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 84.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -66.7% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 3,552.11M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | −40.6% |
| 3 months | −48.4% |
| 6 months | −50.8% |
| 1 year | −28.2% |
| 3 years | +120.3% |
| 5 years | +86.0% |
Signals
| 50-day / 200-day average | 181.84 / 220.16 |
|---|---|
| Golden / death cross (60 days) | Death, 23 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.08 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.